423P Fruquintinib plus sintilimab in refractory repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Preliminary clinical results and biomarker analyses from a phase II study

作者：Weimin Zhang, Yulin Sun, Zhichao Jiang, Tielong Liu, Changlin Gong, Lingling Yang, Y. Xin, Dianye Huang, Aiping Zhou · 发表于：Annals of Oncology · 年份：2022 · DOI：10.1016/j.annonc.2022.07.561 · 被引用次数：9 · 研究领域：Colorectal Cancer Treatments and Studies、Cancer Genomics and Diagnostics、Cancer Immunotherapy and Biomarkers